The primary structure of a cell-binding bone sialoprotein.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMID 3198635)

Published in J Biol Chem on December 25, 1988

Authors

A Oldberg1, A Franzén, D Heinegård

Author Affiliations

1: Department of Physiological Chemistry, University of Lund, Sweden.

Articles citing this

Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol (2010) 2.97

Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A (1990) 2.90

Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J (1996) 2.89

Multiple domains of the large fibroblast proteoglycan, versican. EMBO J (1989) 2.86

Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition. Chem Rev (2008) 2.65

Experimental Staphylococcus aureus arthritis in mice. Infect Immun (1991) 2.24

Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formation. Biochem J (1994) 2.04

Biomimetic systems for hydroxyapatite mineralization inspired by bone and enamel. Chem Rev (2008) 1.96

A bone sialoprotein-binding protein from Staphylococcus aureus: a member of the staphylococcal Sdr family. Biochem J (2000) 1.82

Modulation of crystal formation by bone phosphoproteins: role of glutamic acid-rich sequences in the nucleation of hydroxyapatite by bone sialoprotein. Biochem J (1994) 1.63

A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J (1989) 1.61

Nell-1-induced bone regeneration in calvarial defects. Am J Pathol (2006) 1.38

Structure and expression of fibulin-2, a novel extracellular matrix protein with multiple EGF-like repeats and consensus motifs for calcium binding. J Cell Biol (1993) 1.34

Distribution of SIBLING proteins in the organic and inorganic phases of rat dentin and bone. Eur J Oral Sci (2008) 1.22

Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome. Mol Ther (2010) 1.10

Echistatin is a potent inhibitor of bone resorption in culture. J Cell Biol (1990) 1.00

Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J (1991) 1.00

Bone matrix proteins: isolation and characterization of a novel cell-binding keratan sulfate proteoglycan (osteoadherin) from bovine bone. J Cell Biol (1998) 0.98

Signals from the surface modulate differentiation of human pluripotent stem cells through glycosaminoglycans and integrins. Proc Natl Acad Sci U S A (2014) 0.95

Expression of bone sialoprotein and osteopontin in breast cancer bone metastases. Clin Exp Metastasis (2000) 0.93

The ratio 1660/1690 cm(-1) measured by infrared microspectroscopy is not specific of enzymatic collagen cross-links in bone tissue. PLoS One (2011) 0.93

Evidence for a calcification process in the trabecular meshwork. Exp Eye Res (2008) 0.91

Staphylococcus aureus causing osteomyelitis binds to a nonapeptide sequence in bone sialoprotein. Biochem J (1997) 0.91

Therapies for the bone in mucopolysaccharidoses. Mol Genet Metab (2014) 0.89

Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome. Drug Des Devel Ther (2015) 0.89

Natural variation in the extent of phosphorylation of bone phosphoproteins as a function of in vivo new bone formation induced by demineralized bone matrix in soft tissue and bony environments. Biochem J (2002) 0.89

Osteogenic proteins (bone sialoprotein and bone morphogenetic protein-7) and dental pulp mineralization. J Mater Sci Mater Med (2002) 0.88

Increased concentrations of bone sialoprotein in joint fluid after knee injury. Ann Rheum Dis (1996) 0.87

Physiology of bone: mineral compartment proteins as candidates for environmental perturbation by lead. Environ Health Perspect (1991) 0.85

Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs (2015) 0.83

Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro. Biochem J (1997) 0.83

Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein). Biochem J (1991) 0.83

Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers. PLoS One (2013) 0.83

Post-translational processing of chicken bone phosphoproteins. Identification of bone (phospho)protein kinase. Biochem J (1990) 0.83

Post-translational processing of chicken bone phosphoproteins. Identification of the bone phosphoproteins of embryonic tibia. Biochem J (1990) 0.82

Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein. Cell Adh Migr (2011) 0.82

Cloning and characterization of the rat bone sialoprotein gene promoter. Biochem J (1993) 0.81

Response of stem cells from different origins to biphasic calcium phosphate bioceramics. Cell Tissue Res (2015) 0.79

Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis. Arthritis Rheumatol (2015) 0.78

Identification of a vitamin D3-response element that overlaps a unique inverted TATA box in the rat bone sialoprotein gene. Biochem J (1996) 0.77

Applications of transgenics in studies of bone sialoprotein. J Cell Physiol (2009) 0.77

Comparing variable-length polyglutamate domains to anchor an osteoinductive collagen-mimetic peptide to diverse bone grafting materials. Int J Oral Maxillofac Implants (2014) 0.77

Isolation of a novel bone glycosylated phosphoprotein with disulphide cross-links to osteonectin. Biochem J (1998) 0.76

Bone sialoprotein does not interact with pro-gelatinase A (MMP-2) or mediate MMP-2 activation. BMC Cancer (2009) 0.75

Well-designed bone-seeking radiolabeled compounds for diagnosis and therapy of bone metastases. Biomed Res Int (2015) 0.75

Articles by these authors

Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A (1986) 5.34

Aggregation of cartilage proteoglycans. 3. Characteristics of the proteins isolated from trypsin digests of aggregates. J Biol Chem (1974) 4.61

Aggregation of cartilage proteoglycans. I. The role of hyaluronic acid. J Biol Chem (1974) 4.39

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J (1994) 3.92

Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J (1984) 3.81

Aggregation of cartilage proteoglycans. II. Oligosaccharide competitors of the proteoglycan-hyaluronic acid interaction. J Biol Chem (1974) 3.62

Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage (2006) 3.10

Distribution of keratan sulfate in cartilage proteoglycans. J Biol Chem (1977) 3.04

Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A (1990) 2.90

Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum (1988) 2.77

Polydispersity of cartilage proteoglycans. Structural variations with size and buoyant density of the molecules. J Biol Chem (1977) 2.74

Determination of serum creatinine by a direct colorimetric method. Clin Chim Acta (1973) 2.60

Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem (1992) 2.58

Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J (1985) 2.55

Extraction, fractionation and characterization of proteoglycans from bovine tracheal cartilage. Biochim Biophys Acta (1972) 2.43

Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem (1999) 2.38

Cartilage oligomeric matrix protein: a novel marker of cartilage turnover detectable in synovial fluid and blood. Br J Rheumatol (1992) 2.32

Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis (2004) 2.25

COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem (1992) 2.18

Interaction of a 59-kDa connective tissue matrix protein with collagen I and collagen II. J Biol Chem (1989) 2.09

Characterization of chondroitin sulfate isolated from trypsin-chymotrypsin digests of cartilage proteoglycans. Arch Biochem Biophys (1974) 2.01

A novel low-molecular weight chondroitin sulphate proteoglycan isolated from cartilage. Biochem J (1981) 1.95

Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen. J Biol Chem (1998) 1.94

Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage (2011) 1.89

The core proteins of large and small interstitial proteoglycans from various connective tissues form distinct subgroups. Biochem J (1985) 1.89

Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem (2000) 1.79

Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest (1995) 1.77

Specific binding of bone sialoprotein to Staphylococcus aureus isolated from patients with osteomyelitis. Eur J Biochem (1989) 1.63

Binding of fibromodulin and decorin to separate sites on fibrillar collagens. J Biol Chem (1993) 1.62

Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint. Br J Rheumatol (1995) 1.61

A collagen-binding 59-kd protein (fibromodulin) is structurally related to the small interstitial proteoglycans PG-S1 and PG-S2 (decorin). EMBO J (1989) 1.61

Immunochemical analysis of cartilage proteoglycans. Antigenic determinants of substructures. Biochem J (1979) 1.61

Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol (1998) 1.60

Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis (1986) 1.60

Cartilage proteoglycan aggregate formation. Role of link protein. Biochem J (1981) 1.55

The proteoglycans aggrecan and Versican form networks with fibulin-2 through their lectin domain binding. J Biol Chem (2001) 1.55

Decorin-binding sites for collagen type I are mainly located in leucine-rich repeats 4-5. J Biol Chem (1995) 1.55

Proteoglycans of hyaline cartilage: Electron-microscopic studies on isolated molecules. Biochem J (1975) 1.54

Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem (1988) 1.54

Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis. Arthritis Res (1999) 1.51

Matrix proteins bound to associatively prepared proteoglycans from bovine cartilage. Biochem J (1979) 1.51

Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem (1994) 1.50

The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol (1997) 1.50

Separation and characterization of two populations of aggregating proteoglycans from cartilage. Biochem J (1985) 1.49

Fractionation of proteoglycans from bovine corneal stroma. Biochem J (1975) 1.45

Articular-cartilage proteoglycans in aging and osteoarthritis. Biochem J (1978) 1.44

Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J Biol Chem (1999) 1.43

Extended and globular protein domains in cartilage proteoglycans. Biochem J (1987) 1.42

Purification and structural characterization of a cartilage matrix protein. Biochem J (1981) 1.41

Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest (1993) 1.40

Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. Ann Rheum Dis (2002) 1.38

Increased levels of proteoglycan fragments in knee joint fluid after injury. Arthritis Rheum (1989) 1.38

Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure. J Biol Chem (1992) 1.38

Goodpasture antigen of the glomerular basement membrane: localization to noncollagenous regions of type IV collagen. Proc Natl Acad Sci U S A (1984) 1.37

Cartilage proteoglycans. Assembly with hyaluronate and link protein as studied by electron microscopy. Biochem J (1988) 1.34

Selective binding of bone matrix sialoprotein to Staphylococcus aureus in osteomyelitis. Lancet (1987) 1.34

Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem (2001) 1.33

Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome. Proc Natl Acad Sci U S A (1984) 1.33

Domain structure of cartilage proteoglycans revealed by rotary shadowing of intact and fragmented molecules. Biochem J (1984) 1.29

Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet (1985) 1.28

2B1 antigen characteristically expressed on extracellular matrices of human malignant tumors is a large chondroitin sulfate proteoglycan, PG-M/versican. Cancer Res (1996) 1.28

Two novel matrix proteins isolated from articular cartilage show wide distributions among connective tissues. J Biol Chem (1986) 1.27

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Ann Rheum Dis (1998) 1.27

A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem (1998) 1.26

The partial amino acid sequence of bovine cartilage proteoglycan, deduced from a cDNA clone, contains numerous Ser-Gly sequences arranged in homologous repeats. Biochem J (1987) 1.23

Fibromodulin distribution and association with collagen. Matrix Biol (1994) 1.22

Characterization of proteoglycans from adult bovine tendon. J Biol Chem (1985) 1.22

Radioimmunoassay of the 148-kilodalton cartilage protein. Distribution of the protein among bovine tissues. Biochem J (1982) 1.22

Hyaluronidase digestion and alkaline treatment of bovine tracheal cartilage proteoglycans. Isolation and characterisation of different keratan sulfate proteins. Biochim Biophys Acta (1972) 1.21

Proteoglycan fragments in joint fluid. Influence of arthrosis and inflammation. Acta Orthop Scand (1992) 1.21

Cartilage oligomeric matrix protein (COMP)-induced arthritis in rats. Clin Exp Immunol (1998) 1.21

Characterization of the keratan sulphate proteoglycans from bovine corneal stroma. Biochem J (1978) 1.20

Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesions. Arthritis Rheum (1992) 1.20

Antiglomerular basement membrane antibody: antibody specificity in different forms of glomerulonephritis. Kidney Int (1983) 1.19

The keratan sulfate-enriched region of bovine cartilage proteoglycan consists of a consecutively repeated hexapeptide motif. J Biol Chem (1989) 1.19

Measurement of synovial fluid volume using albumin dilution upon intraarticular saline injection. J Rheumatol (1988) 1.18

Assay of proteoglycan populations using agarose-polyacrylamide gel electrophoresis. Anal Biochem (1985) 1.15

Patients with IgA nephropathy have circulating anti-basement membrane antibodies reacting with structures common to collagen I, II, and IV. Proc Natl Acad Sci U S A (1986) 1.15

Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biol (1995) 1.14

Cartilage metabolism in the injured and uninjured knee of the same patient. Ann Rheum Dis (1994) 1.14

Cartilage proteoglycans in synovial fluid and serum in patients with inflammatory joint disease. Relation to systemic treatment. Arthritis Rheum (1987) 1.14

Association of chondroadherin with collagen type II. J Biol Chem (2001) 1.13

Chemical and physical changes in proteoglycans during development of chick limb bud chondrocytes grown in vitro. J Biol Chem (1977) 1.13

Characterization of proteoglycans from the calcified matrix of bovine bone. Biochem J (1984) 1.12

Studies on protein-polysaccharide complex (proteoglycan) from human nucleus pulposus. I. Isolation and preliminary characterisation. Biochim Biophys Acta (1967) 1.12

Specific interaction between cartilage proteoglycans and hyaluronic acid at the chondrocyte cell surface. Biochem J (1983) 1.12

Metabolism of cartilage proteins in cultured tissue sections. Biochem J (1983) 1.12

The primary structure of a basic leucine-rich repeat protein, PRELP, found in connective tissues. J Biol Chem (1995) 1.12

The cartilage proteoglycan aggregate: assembly through combined protein-carbohydrate and protein-protein interactions. Biophys Chem (1994) 1.11

Isolation and characterization of proteoglycans. Methods Enzymol (1987) 1.11